Your session is about to expire
← Back to Search
Midazolam Sedation for Endoscopy
This trial is designed to see if midazolam alone is as effective and safe as a combination of midazolam and fentanyl for GI endoscopy.
- Conscious Sedation
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a Location
Who is running the clinical trial?
- You have had an allergic reaction or a bad experience with fentanyl or midazolam in the past.You are pregnant.
- Group 1: midazolam and fentanyl
- Group 2: midazolam alone
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there still opportunities for individuals to participate in this research?
"Affirmative. Clinicaltrials.gov provides evidence that this research project, which launched on April 5th 2021, is actively recruiting subjects. Approximately 772 participants are sought from a single medical facility."
Is midazolam being studied independently in any other investigations?
"Presently, there are 65 ongoing experiments studying the effects of midazolam alone. 10 of those trials have reached Phase 3 and the majority of them are located in Porto Alegre, California while 724 other medical centres run clinical studies involving this medication."
Is this trial accepting participants aged 25 or older?
"According to the stated rules of this trial, only individuals between 18 and 75 years old qualify. There are 58 studies open for minors while 156 trials focus on seniors."
In what treatments is midazolam administered as a sole agent?
"Midazolam is commonly administered to provide tranquillity, and has been used to induce forgetfulness, combat convulsive seizures, and treat the symptoms of anxiety."
How extensive is the participant pool for this research endeavor?
"Affirmative. Per the information on clinicaltrials.gov, this research is still recruiting participants who meet the eligibility criteria. It was first posted on April 5th 2021 and last updated July 26th 2021. The study requires 772 enrollees from a single location to be completed successfully."
Who would be the ideal subjects for this research endeavor?
"In order to participate in this medical trial, candidates must have previously undergone endoscopy and be age 18-75. Currently, 772 individuals are being recruited."
What are the major goals of this clinical trial?
"This trial will measure sedation effectiveness over a 24 hour period and also take into account secondary performance metrics such as desaturation, hypotension and withdrawal time. These latter measurements are derived from nurse reported observations combined with retrospective chart reviews."
Share this study with friends